Thank you very much.
I'm going to follow up on the question that Ms. Morin raised, and that is the role of pharmaceuticals. First of all, I believe we are going to hear from Rx&D, because I happened to run into one of their representatives today and I think they are coming to our last meeting, so we will hear from them directly.
Who monitors what is being sent to physicians and whether or not the information is appropriate? Dr. Simpson, you talked about how in remote areas physicians are pretty well on their own; they don't have a multidisciplinary team or other colleagues who they can go to. I'm just curious to know. We're talking about a multi-billion dollar industry here, so obviously there's the issue of pushing new prescriptions. I've seen those books in doctors' offices. They're huge, and you sometimes see physicians flipping through them, but who monitors that? Is there any monitoring? Do we need to pay attention to that to make sure that it's not just a marketing thing, but that it really is centred on proper guidance about what an appropriate prescription is?